Funding profile · Pet health ingredients

Kingdom

One Form D in the company’s life, filed under a name nobody searches for, reporting $3.4 million more than the round the company announced. Five years later the company says it has raised $40 million. The records account for about $31.9 million of it.

$28.4MSold in the only Form D on record, filed Nov 2, 2021
93Investors in that offering, about $305,300 each
$40MTotal raised, company-stated, September 2026
$8.1MGap between that figure and the documented record

Data as of September 22, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
2020 Y Combinator, Summer 2020 Not disclosed Y Combinator YC data
2020 Seed $3.5M Sequoia, Y Combinator, Lakehouse Ventures, Brand Foundry Ventures Company release
Sep to Nov 2021 Series A $25.0M announced; $28,397,117 sold per the filing Led by Shine Capital; Valor, Tao, Lux, SALT, Reference, Digitalis; founders of Daring Foods, Good Culture, Hungryroot, RXBAR and Waterloo Form D and release
Aug 2023 Grant, per a funding aggregator $650K Not named Aggregator
By Sep 2026 Cumulative $40M Not named Company-stated

What the filings show

Imvela Corp. · Form D · filed Nov 2, 2021

First sale
Sep 13, 2021
Offered
$28,397,117 equity
Sold
$28,397,117 · $0 remaining
Investors
93 · average about $305,300 · no non-accredited investors
Exemption
Rule 506(b)
Fees
Sales commissions $0 · finders fees $0
Revenue range
Decline to disclose
Related persons
Kendall Dabaghi (executive officer, director); Ravi Sheth (executive officer, director); Mo Koyfman (director)
Signed
Kendall Dabaghi, President, Oct 30, 2021
Filing
SEC EDGAR, CIK 0001841793

Reading the filings

  1. The filed number is bigger than the announced number.The October 5, 2021 release called it a $25 million Series A. The Form D filed four weeks later reports $28,397,117 offered and the same amount sold, with nothing remaining. That is $3,397,117 more than the press figure, about 13.6 percent above it. Rounding down for a headline is common; the filing is the number that was signed.
  2. Ninety three investors is a crowd.$28,397,117 across 93 investors averages about $305,300 each. A six fund round does not produce 93 names. It fits the release, which lists six institutions plus the founders of Daring Foods, Good Culture, Hungryroot, RXBAR and Waterloo. The long tail of angels shows up in the investor count rather than in the dollar total.
  3. The filing was late and the announcement came first.First sale was September 13, 2021. A Form D is due within 15 days of first sale, which would be about September 28. The press release went out October 5, the form was signed October 30, and it reached EDGAR on November 2, roughly 50 days after the first sale. Nothing about that changes the economics, but it means the public heard the number before the regulator did.
  4. Nobody searching for this company by name would find it.The issuer is Imvela Corp., a Delaware corporation in the Brooklyn Navy Yard. EDGAR company search returns no match for Kingdom Supercultures or Kingdom Superculture, and EDGAR full text search returns zero documents for either. The link between the brand and the filer appears in a 2021 trademark application, where Imvela Corp is listed as the owner of the mark KINGDOM SUPERCULTURES. Screening databases keyed to the trading name will show this company as having never filed.
  5. One filing in seven years.The 2020 seed round of $3.5 million has no Form D under Imvela Corp or either Kingdom name, and no filing has been made since November 2021. Issuers that raise under Section 4(a)(2) rather than Regulation D file nothing, so the absence is not evidence that no money moved. It does mean the SEC record covers a single offering.
  6. The company total and the record do not meet.In a September 2026 interview the CEO said the company has raised $40 million. Public records support $28,397,117 from the Form D plus a reported $3.5 million seed, or $31.9 million. A funding aggregator adds a $650,000 grant in August 2023 and puts the lifetime total at $30.4 million. The unexplained remainder is roughly $8.1 million, and no filing on EDGAR accounts for it.

Commercial signals

Signal Detail Source type
Products Two ingredients in market: Superculture Pet Oral and Superculture Pet Immune, both sold to brands rather than to consumers. Company-stated
Named customers Dinovite, Native Pet and Woof, repeated by Pet Food Processing in May 2026. More than a dozen brands claimed in May 2026, dozens by September 2026, rest unnamed. Company-stated
Evidence Five peer reviewed papers, four of them indexed in PubMed, all authored solely by Kingdom staff. Nine company run trials completed, three in progress. Public record
Certification Listed as a Preferred Supplier by the National Animal Supplement Council, a status that has to be re-earned annually. Certifier
Retail traction About one in three products built on Pet Oral earned a number one new release badge on Amazon shortly after launch, and one Pet Immune product was named second best new dog product at Global Pet Expo 2026. Company-stated
Headcount 18 on the Y Combinator profile, 20 in the September 2026 interview, with one in three described as PhD holders. Company-stated
Adjacent market Two human trials of a deodorant postbiotic called NOBO, registered under the sponsor name Kingdom and completed in 2026 at the company’s own Brooklyn site. Public record

What to watch

  • A Form D covering whatever closed after November 2021. There is $8.1 million between the company total and the record.
  • Whether the Delaware entity is renamed, which would put future filings under a searchable name.
  • Customer concentration. Three named brands against a claim of dozens.
  • Whether the human deodorant work becomes a second product line, a licensing deal, or a separate entity.
  • Any trial of either ingredient run by a group that Kingdom does not employ.

The Kingdom story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Aegis: Shared investor: Sequoia. A three person Y Combinator startup building AI agents that detect denied health insurance claims, draft the appeal, and file it, aiming to turn a two hour manual task
  • Avora: Shared investor: Sequoia. A San Francisco startup that builds AI agents to listen in on dental appointments, draft the clinical notes, and coach staff on how they present treatment plans
  • Comprehend Systems: Shared investor: Sequoia. A Y Combinator company that sold software for watching clinical trials while they were still running
  • Zeit Medical: Shared investor: Sequoia. A soft EEG headband built to notice a stroke while its wearer is asleep and raise the alarm before anyone else can

Sources

  1. Public recordForm D, Imvela Corp., CIK 0001841793, accession 0001841793-21-000004SEC · Nov 2, 2021
  2. Public recordEDGAR company search and full text search for Kingdom Supercultures and ImvelaSEC · Sep 22, 2026
  3. Public recordTrademark application 90878768, KINGDOM SUPERCULTURES, owner Imvela CorpUSPTO · filed Aug 12, 2021
  4. Public recordClinicalTrials.gov NCT07547761 and NCT07726238, sponsor KingdomRetrieved Sep 22, 2026
  5. IndependentMicrobial cultures supplier raises $25 millionFood Business News, Sam Danley · Oct 5, 2021
  6. IndependentSpeeding up serendipity: How Kingdom Supercultures will use $25M to create better foods through fermentationFood Dive, Megan Poinski · Oct 5, 2021
  7. IndependentKingdom Superculture Pet Oral shown to support dog oral healthPet Food Processing, Nicole Kerwin · May 15, 2026
  8. InterviewInterview With Co-Founder And CEO Kendall Dabaghi About Postbiotics For Pet HealthPulse 2.0, Amit Chowdhry · Sep 14, 2026
  9. AggregatorKingdom Supercultures funding history, four roundsIndexed.vc · accessed Sep 22, 2026
  10. CompanyKingdom Supercultures Raises $25 Million Series APR Newswire · Oct 5, 2021
  11. CompanyTwo New Studies Show Breakthrough Superculture Ingredients Are Putting an End to Doggy BreathPR Newswire · May 12, 2026

Compiled from SEC, USPTO, ClinicalTrials.gov and PubMed public records and published reports as of September 22, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date and may not capture later sales. Healthcare Venture Capital Fund holds no position in Kingdom. This page is not an offer to sell or a recommendation to buy any security.